Carpal Tunnel Syndrome
Clinical Snapshot
Carpal tunnel syndrome (CTS) is the most common entrapment (compressive) mononeuropathy, caused by compression of the median nerve as it passes through the carpal tunnel at the wrist — a rigid space bounded by the carpal bones dorsally and the transverse carpal ligament (flexor retinaculum) volarly, shared with the 9 flexor tendons of the fingers and thumb. Any process that raises pressure within this fixed space — flexor tenosynovium swelling, fluid retention, a space-occupying lesion, or simple mechanical narrowing from repetitive wrist motion — compresses the nerve and, over time, produces both ischemic and structural nerve injury.[1]
CTS affects roughly 3% of the general adult population, with women affected about 3 times as often as men, and both prevalence and severity increasing with age.[2] The classic presentation is nocturnal numbness, tingling, or burning pain in the thumb, index finger, middle finger, and the radial (thumb-side) half of the ring finger — the sensory territory of the median nerve — while the little finger and the ulnar half of the ring finger are characteristically spared. This sparing pattern is one of the most useful bedside clues distinguishing CTS from ulnar neuropathy at the elbow (cubital tunnel syndrome), which produces the mirror-image pattern.[2] Diagnosis remains fundamentally clinical — a compatible history plus supportive examination findings — with electrodiagnostic testing reserved for confirmation, severity grading, or diagnostic uncertainty rather than as a required first step.[3]
Recognize the Condition
Typical symptom pattern
Most patients first notice intermittent numbness, tingling ("pins and needles"), or a burning sensation in the median-nerve distribution — thumb, index finger, middle finger, and the radial half of the ring finger — that is characteristically worse at night and often wakes the patient from sleep. Many patients instinctively shake or flick the hand for relief; this "flick sign" is itself one of the more accurate bedside findings.[2] Symptoms are also commonly provoked by sustained wrist flexion or extension — driving, holding a phone or book, cycling, or repetitive gripping or typing tasks. As compression becomes more sustained, numbness can become constant rather than intermittent, and patients may describe clumsiness, dropped objects, or difficulty with fine motor tasks (buttoning a shirt, picking up small objects) as thumb opposition and pinch strength decline.[1]
Advanced disease — thenar wasting
With longer-standing or more severe compression, visible thenar eminence atrophy and demonstrable weakness of thumb abduction and opposition (median-innervated intrinsic muscles) can develop. This is a sign of significant axonal loss, not simply ongoing reversible nerve irritation, and its presence changes the management plan directly — see Red Flags & Refer.[2]
Provocative examination maneuvers
No single bedside test is sensitive and specific enough to confirm or exclude CTS on its own; used together, and interpreted against the overall clinical picture, they meaningfully raise or lower the probability of the diagnosis.[2]
| Maneuver | How it is performed | Sensitivity | Specificity |
|---|---|---|---|
| Flick sign | Ask the patient whether shaking or flicking the hand relieves symptoms | 93% | 96% |
| Phalen maneuver | Hold both wrists in full, unforced flexion (backs of the hands together) for up to 60 seconds; positive if paresthesia reproduces in the median distribution | 57-68% | 58-73% |
| Median nerve (Durkan) compression test | Apply direct thumb pressure over the carpal tunnel/median nerve at the wrist for up to 30 seconds | 64% | 83% |
| Classic/probable symptom hand diagram | Patient shades a hand diagram to show where symptoms occur; a classic or probable pattern (sparing the little finger) supports the diagnosis | 64-75% | 73% |
| Tinel sign | Lightly tap over the median nerve at the wrist crease; positive if it reproduces tingling in the median distribution | 36-50% | 77% |
Differentiating CTS from its mimics
| Condition | Key distinguishing features |
|---|---|
| Ulnar neuropathy (cubital tunnel syndrome) | Numbness/tingling in the little finger and ulnar half of the ring finger — sparing the thumb, index, and middle fingers — the mirror image of CTS; often worse with sustained elbow flexion (e.g., holding a phone) rather than wrist position. |
| Cervical radiculopathy (C6-C7) | Neck pain radiating down the arm, symptoms not confined to a single peripheral nerve's territory, and neck movement (not wrist position) reproducing symptoms; reflex and dermatomal changes support a nerve-root rather than wrist-level lesion. |
| Thoracic outlet syndrome | Symptoms affecting the whole hand or forearm, often with positional or vascular features (colour change, swelling), provoked by overhead arm positioning rather than wrist flexion/extension. |
| Diabetic (or other) peripheral polyneuropathy | Symmetric, stocking-glove distribution extending beyond a single nerve's territory, usually with lower-extremity involvement as well. |
| De Quervain tenosynovitis | Pain, not numbness, localized to the radial wrist/thumb base, reproduced by resisted thumb extension or ulnar deviation with the thumb clasped (Finkelstein test) — a tendon problem, not a nerve compression. |
Risk Factors
- Repetitive or forceful wrist motion, particularly occupational — forceful hand exertion is the single most consistently identified occupational risk factor, with vibrating power tools, repetitive gripping, and prolonged non-neutral wrist postures (assembly-line, meatpacking, and similar manual trades) also implicated.[2]
- Pregnancy — a common and usually self-limited cause related to fluid retention and soft-tissue swelling within the carpal tunnel; most often develops in the second or third trimester and is frequently bilateral.[4]
- Obesity.
- Diabetes mellitus — both a mechanical risk factor and a cause of a separate, coexisting peripheral polyneuropathy that can complicate the presentation.[2]
- Hypothyroidism — myxedematous soft-tissue swelling within the carpal tunnel.[2]
- Rheumatoid arthritis and other inflammatory arthropathies — flexor tenosynovitis narrows the available space in the tunnel.[2]
- Female sex and increasing age.[2]
- A personal or family history of CTS, and anatomic factors that produce a smaller carpal tunnel cross-sectional area.
- Less common causes: wrist trauma or fracture (including acute, post-traumatic CTS — see Red Flags & Refer), amyloidosis (including dialysis-related amyloid deposition in patients on long-term hemodialysis), acromegaly, and other space-occupying lesions (ganglion cyst, lipoma, anomalous muscle).
Red Flags & Refer
Most CTS is managed conservatively at first presentation, but the following findings should prompt more urgent action — either bypassing a further conservative trial in favour of surgical referral, or investigating for a distinct underlying cause:
- Thenar eminence atrophy or measurable thumb abduction/opposition weakness — this reflects significant axonal loss rather than simple reversible nerve irritation; refer for surgical evaluation rather than extending a conservative trial.[2]
- Constant (rather than intermittent/nocturnal) numbness — suggests more advanced compression and a lower chance of full reversal with conservative measures alone.
- Rapidly progressive symptoms over days to a few weeks, rather than the typical gradual course over months.
- Acute carpal tunnel syndrome following wrist trauma (e.g., a distal radius fracture, crush injury, or hematoma) — this is a surgical emergency requiring urgent decompression, not a candidate for the routine outpatient conservative pathway.
- Bilateral symptoms — raises the likelihood of a systemic contributing cause (diabetes, hypothyroidism, rheumatoid arthritis, renal disease/dialysis-related amyloidosis) that itself needs assessment and treatment, not just bilateral splinting.
- Sensory or motor findings extending beyond the median nerve's territory, or symptoms not fitting the classic/probable hand-diagram pattern — reconsider the differential diagnosis (cervical radiculopathy, peripheral polyneuropathy, thoracic outlet syndrome, or a combined "double crush" lesion) rather than assuming atypical CTS.
- No improvement, or objective electrodiagnostic evidence of ongoing axonal loss/denervation, after an adequate conservative trial — proceed to surgical referral rather than repeating conservative measures indefinitely.[2]
Assessment & Diagnosis
History
Characterize the distribution (classic median-nerve pattern sparing the little finger), timing (nocturnal predominance, symptoms on waking), and specific provoking activities (driving, phone use, cycling, repetitive gripping or typing). Ask about occupational and hobby-related repetitive wrist use, and screen directly for the systemic risk factors above — pregnancy, diabetes, hypothyroidism, and inflammatory arthritis — particularly when symptoms are bilateral.
Examination
Combine the provocative maneuvers described in Recognize the Condition (flick sign, Phalen maneuver, median nerve compression test, Tinel sign) with a focused assessment of thenar bulk and strength (thumb abduction and opposition against resistance) and sensation in the median distribution. No single maneuver is both sensitive and specific enough to stand alone; a compatible history plus 2 or more positive findings meaningfully raises diagnostic confidence.[2]
Electrodiagnostic studies (nerve conduction studies / EMG)
Electrodiagnostic testing is not required to begin conservative therapy in a patient with a classic history and examination, but plays a genuine role in 3 specific situations: confirming the diagnosis when the presentation is atypical or the differential remains open, grading severity (useful for prognosis and for planning conservative versus surgical management), and, per current guidance, before proceeding to surgery.[2] Sensitivity is reported at 56-85% and specificity at 94-99%, but results can be normal in up to one-third of clinically mild cases — a normal study does not exclude the diagnosis in a patient with a compatible history and examination.[2] A dedicated Canadian study directly comparing symptom severity to nerve conduction study findings found the two do not always match — some patients with substantial symptoms have normal or only mildly abnormal studies, and vice versa — reinforcing that electrodiagnostic testing is a confirmatory and severity-grading adjunct to the clinical diagnosis, not a gatekeeper for it.[3]
Laboratory testing
Reserve laboratory testing for a specific indication raised by the history or examination rather than ordering it routinely — fasting glucose or HbA1c and TSH are reasonable in bilateral CTS or when other systemic risk-factor features are present, rather than in every patient with a classic unilateral presentation.
Treatment Targets
- Relieve nocturnal and activity-provoked paresthesia and pain.
- Prevent progression to constant sensory loss and thenar motor weakness/atrophy — the point past which conservative measures are far less likely to fully reverse nerve injury.
- Preserve grip strength, pinch strength, and fine motor function for work, hobbies, and activities of daily living.
- Identify and address reversible or modifiable contributing factors — occupational ergonomics, obesity, undertreated diabetes or hypothyroidism — alongside direct treatment of the nerve compression itself.
- Avoid unnecessary surgery in presentations that are genuinely likely to be self-limited, most notably pregnancy-related CTS, while not delaying surgical referral once it is actually indicated.
- Set realistic expectations: conservative therapy (splinting, injection) reliably provides symptom relief for weeks to many months, but a substantial proportion of patients — particularly those with more than mild disease — eventually need surgery for durable relief.[5]
Choose Initial Treatment
Start conservative for mild-to-moderate disease without a red flag
Management follows a stepped sequence — splinting, then corticosteroid injection, then surgery — rather than offering every option at once; which step is appropriate for a given patient depends on symptom severity, prior treatment, and whether any red-flag feature is present.[6]
1st line, every patient without a red flag a neutral-position wrist splint, worn especially overnight, combined with activity/ergonomic modification to reduce provoking wrist motion — splinting is more effective than no treatment, and a neutral (0°) wrist position outperforms an extension splint.[7]
Adjunct for symptomatic relief a short course of oral therapy can be offered alongside splinting while it takes effect. Oral prednisone (20 mg daily for 10-14 days) has evidence of genuine short-term symptom benefit, lasting up to about 8 weeks — a reasonable option for a patient who wants to avoid an injection.[2] Oral NSAIDs are commonly self-selected by patients for the associated discomfort, but neither the dedicated Cochrane review of non-splint, non-injection conservative therapies nor the current AFP evidence summary found NSAIDs effective specifically for CTS symptom relief — counsel honestly that they are unlikely to change the underlying nerve-compression symptoms, and reserve them for a genuine coexisting nociceptive complaint rather than presenting them as primary CTS therapy.[8][2]
Escalating for moderate disease not responding to splinting
Corticosteroid injection for patients with persistent moderate symptoms after an adequate splinting trial (typically 2-6 weeks), or when faster relief is genuinely needed — local corticosteroid injection gives real short-term benefit over placebo, with improvement commonly lasting 10 weeks to over a year in some patients, though most patients treated with injection alone eventually go on to need further treatment.[9][2] See Drug Tables for injection technique and dosing.
Surgical referral
Refer for surgical evaluation when any red-flag feature is present (thenar wasting/weakness, constant numbness, acute post-traumatic CTS), when electrodiagnostic testing shows ongoing axonal loss/denervation, or when symptoms have not adequately responded to about 4-6 months of conservative therapy.[2] Head-to-head evidence now directly supports this sequencing: surgery produces more effective and more durable relief than corticosteroid injection alone for patients whose symptoms persist,[5] and a broader comparison of surgical versus non-surgical treatment overall likewise favours surgery for confirmed CTS that has not responded to an adequate conservative trial.[10] Open and endoscopic carpal tunnel release both achieve good long-term outcomes in 70-90% of patients; endoscopic release is associated with an earlier return to work.[2]
Non-Pharmacologic Treatment
Wrist splinting — the foundation of conservative therapy
A neutral-position (0°, not extended) wrist splint is the best-supported non-drug intervention, worn especially overnight since symptoms are typically worst during sleep from unconscious wrist flexion; many patients also benefit from wearing it during specific daytime activities that reliably provoke symptoms (driving, prolonged typing, repetitive gripping).[7] A typical initial trial runs 2-6 weeks before reassessing response.
Activity and ergonomic modification
Reduce sustained or repetitive wrist flexion/extension and forceful gripping where possible: adjust keyboard and mouse height and wrist position, take regular breaks from repetitive tasks, modify grip technique or tool selection for vibrating power tools, and address any specific occupational exposure identified in the history.
Nerve and tendon gliding exercises
Structured nerve-gliding exercises, therapeutic ultrasound, and carpal bone mobilization are reasonable low-risk adjuncts to splinting, though the supporting evidence is more limited than for splinting itself.[2]
Addressing modifiable contributing factors
Weight loss in a patient who is overweight or obese, improved glycemic control in diabetes, and treatment of underlying hypothyroidism or inflammatory arthritis are reasonable parallel goals — these do not replace direct treatment of the nerve compression itself, but can reduce the mechanical/soft-tissue contribution to it over time.
Patient education and expected course
Explain the anatomic basis of the condition in plain terms — a nerve being compressed within a fixed space, not a "pinched nerve" that will necessarily resolve on its own if ignored — and set explicit expectations: mild-to-moderate CTS responds well to splinting and, if needed, injection in most patients, but thenar wasting or a poor response to an adequate conservative trial changes the plan toward surgery rather than continued conservative measures. For pregnancy-related CTS specifically, reassure that most cases improve substantially or resolve within weeks to a few months after delivery, which should meaningfully lower the threshold for choosing conservative management over injection or surgery during pregnancy itself.[4]
Special Populations
Pregnancy
CTS is common in pregnancy, most often developing in the second or third trimester as fluid retention and soft-tissue swelling raise pressure within the carpal tunnel, and is frequently bilateral.[4] Preferred favour conservative management — neutral wrist splinting — as first-line therapy; the large majority of pregnancy-related CTS improves substantially or resolves within weeks to a few months after delivery, which should lower the threshold for conservative management over injection or surgery during pregnancy itself.[4] If splinting alone is inadequate a corticosteroid injection can still be considered on an individualized basis when symptoms are more than mild, weighing the generally reassuring local-injection risk profile against the high likelihood of spontaneous postpartum improvement. Avoid NSAIDs from approximately 20 weeks of pregnancy onward Health Canada has confirmed a risk of fetal renal impairment and low amniotic fluid (oligohydramnios) with NSAID use from about 20 weeks, and NSAIDs are contraindicated in the third trimester for this reason — independent of their limited CTS-specific benefit discussed in Choose Initial Treatment.[11] Reserve surgery in pregnancy for the same red-flag indications used outside pregnancy (thenar wasting/weakness, constant numbness, no improvement despite conservative measures) rather than as a routine option, given the strong likelihood of spontaneous improvement.
Breastfeeding
Wrist splinting and activity modification carry no breastfeeding-specific concern. A local corticosteroid injection into the carpal tunnel delivers a small, localized dose and is not expected to meaningfully affect a breastfed infant; confirm specifics for any oral corticosteroid course against its own Drug Database entry before use.
Pediatric
CTS is rare in children. When it does occur, evaluate for an underlying structural or metabolic cause (a mucopolysaccharidosis, a connective tissue disorder, prior wrist trauma, or a space-occupying lesion) rather than assuming an adult-pattern repetitive-use etiology, and refer to a pediatric specialist for both diagnosis and management.
Older adults
Prevalence increases with age, and coexisting cervical spondylosis or peripheral polyneuropathy is more common in this group, which can blur the clinical picture (a "double crush" pattern) — maintain a lower threshold for electrodiagnostic testing when the presentation is not entirely classic. Use oral corticosteroid courses cautiously given the higher prevalence of diabetes, osteoporosis, and other corticosteroid-sensitive comorbidities in this age group.
Diabetes and renal impairment/dialysis
In diabetes, CTS can reflect a combination of true mechanical nerve compression and a separate diabetic peripheral polyneuropathy — both may need independent assessment and treatment. Corticosteroid injection remains a reasonable option in diabetes, but counsel patients to monitor blood glucose more closely for several days afterward given the risk of transient hyperglycemia. In patients on long-term hemodialysis, consider dialysis-related amyloid deposition as a specific contributing cause, particularly with bilateral or atypical presentations.
Bilateral CTS
Bilateral symptoms should prompt screening for an underlying systemic cause (diabetes, hypothyroidism, rheumatoid arthritis, renal disease) rather than treating both wrists as 2 independent, unrelated mechanical problems.
Monitoring & Follow-Up
Reassess response to a wrist splint at 2-6 weeks — both symptom improvement and confirmation the splint is actually being worn correctly and consistently, especially overnight.
- At each visit, track the pattern and frequency of paresthesia, grip and pinch strength, and specifically look for new or worsening thenar bulk loss or weakness.
- After a corticosteroid injection, reassess at 2-6 weeks; most benefit is apparent by this point, though full effect can take longer.[9]
- For a patient managed conservatively long-term, reassess periodically (e.g., every 3-6 months, sooner if symptoms change) for any new red-flag finding — this is a condition that can progress from reversible to less-reversible nerve injury, and a patient stable for years can still develop new thenar weakness that changes the plan.
- Confirm any reversible contributing factor identified at diagnosis (glycemic control, thyroid status, weight, ergonomic exposure) is being actively addressed, not just the nerve compression itself.
- For a patient who received oral prednisone, confirm the short course was completed as prescribed and was not repeated or extended without re-evaluation.
Common Errors to Avoid
- Diagnosing CTS from symptom description alone, without any provocative examination maneuver or consideration of the differential diagnosis — particularly ulnar neuropathy and cervical radiculopathy.
- Assuming little-finger involvement is simply "atypical CTS" rather than raising suspicion for ulnar neuropathy or a combined neuropathy.
- Ordering electrodiagnostic studies as a routine first step in every suspected case — they are not required to begin conservative therapy in a classic presentation and are better reserved for diagnostic uncertainty, severity grading, or the pre-surgical work-up.[3]
- Treating a normal nerve conduction study as ruling out CTS in a patient with a clearly compatible history and examination — up to a third of mild cases are electrodiagnostically normal.[2]
- Relying on oral NSAIDs as primary CTS therapy — evidence does not support a CTS-specific benefit, and this can delay effective treatment (splinting, injection, or surgery).[8]
- Continuing to repeat corticosteroid injections indefinitely in a patient with an inadequate or short-lived response, instead of referring for surgery once that pattern is clear.[5]
- Delaying surgical referral in a patient who already has thenar wasting or weakness while pursuing further conservative trials.
- Missing bilateral CTS as a clue to an undiagnosed or undertreated systemic condition (diabetes, hypothyroidism, rheumatoid arthritis, renal disease).
- Defaulting to surgery for pregnancy-related CTS rather than favouring conservative management, given the strong likelihood of spontaneous postpartum resolution.[4]
- Injecting a corticosteroid directly into the median nerve rather than using proper technique (an ulnar approach, lateral to the palmaris longus tendon) to avoid nerve injury.
Clinical Decision Algorithm
Drug Tables
How to use this table: doses are adult doses and require patient-specific confirmation, including renal/hepatic adjustment. Select any drug name to open its complete Pharmasist Drug Database page.
Corticosteroid injection into the carpal tunnel
Technique matters as much as drug choice: inject using an ulnar approach, entering the wrist crease just ulnar (medial) to the palmaris longus tendon (or, if that tendon is absent, roughly 1 cm ulnar to the flexor carpi radialis tendon), angled distally and superficially to avoid the median nerve itself — never inject if the patient reports sharp, shooting pain suggesting needle contact with the nerve. Not a pharmacist-initiated procedure; performed by a physician or advanced-practice clinician trained in the technique.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Methylprednisolone acetate / lidocaine | Adults: 1 mL (40 mg methylprednisolone acetate with lidocaine) injected into the carpal tunnel; may repeat once, generally after several weeks, for a partial or recurrent response | Local pain/bruising at the injection site, transient hyperglycemia in patients with diabetes, skin or subcutaneous fat atrophy with repeated injection, rare tendon or nerve injury with poor technique | None significant at the small local-infiltration volumes used for carpal tunnel injection | A pre-mixed combination product (methylprednisolone acetate 40 mg/mL with lidocaine 10 mg/mL) that provides both the corticosteroid effect and immediate procedural analgesia in a single injection. |
| Triamcinolone (acetonide) | Adults: 20-40 mg triamcinolone acetonide mixed with lidocaine, injected into the carpal tunnel using the same technique | As above | As above | An alternative corticosteroid where the pre-mixed methylprednisolone/lidocaine product is unavailable; mix with a small volume of lidocaine before injection. |
| Lidocaine | Adults: A small volume of 1% lidocaine mixed with the corticosteroid dose | Local stinging on injection; systemic toxicity is rare with appropriate local infiltration technique | None significant at the small local-infiltration volumes used here | Added to triamcinolone (which is not pre-mixed with an anesthetic) to reduce injection discomfort; not required alongside the methylprednisolone/lidocaine combination product. |
Oral therapy
A short, defined course only — not a substitute for splinting, and not intended for repeated or open-ended use.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Prednisone | Adults: 20 mg PO once daily for 10-14 days | Hyperglycemia, insomnia, mood change, increased appetite, GI upset; avoid repeated or prolonged courses given the usual systemic corticosteroid risks | Additive hyperglycemic effect with other drugs that raise blood glucose; NSAID co-administration increases GI bleeding risk | Genuine short-term symptom benefit demonstrated over roughly 10-14 days of therapy, with benefit lasting up to about 8 weeks; a reasonable option for a patient who prefers to avoid an injection. |
NSAIDs — no established CTS-specific benefit
Included because patients frequently self-select or ask about these, not because they are recommended as CTS-specific therapy; reasonable only for a genuine coexisting nociceptive/inflammatory complaint.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Ibuprofen | Adults: No CTS-specific dose established — use the lowest effective dose for the shortest duration for a genuine coexisting complaint | GI upset/bleeding, renal impairment, cardiovascular risk, fluid retention | Increased bleeding risk with anticoagulants; may reduce the antihypertensive effect of ACE inhibitors, ARBs, and diuretics; avoid combining with another NSAID | Neither the dedicated Cochrane review of non-splint, non-injection conservative therapies nor current AFP evidence found NSAIDs effective specifically for CTS symptom relief. |
| Naproxen | Adults: No CTS-specific dose established — use the lowest effective dose for the shortest duration for a genuine coexisting complaint | GI upset/bleeding, renal impairment, cardiovascular risk, fluid retention | Same cautions as ibuprofen | Same evidence limitation as ibuprofen for CTS specifically. |
References
- American Academy of Orthopaedic Surgeons/ASSH Clinical Practice Guideline Summary: Management of Carpal Tunnel Syndrome — Journal of the American Academy of Orthopaedic Surgeons (Shapiro LM, Kamal RN, et al.). J Am Acad Orthop Surg 2025;33(7):e356-e366
- Carpal Tunnel Syndrome: Diagnosis and Management — American Family Physician (Wipperman J, Goerl K). Am Fam Physician 2016;94(12):993-999
- Suspected carpal tunnel syndrome: Do nerve conduction study results and symptoms match? — Canadian Family Physician (Taylor-Gjevre RM, Gjevre JA, Nair B). Can Fam Physician 2010;56(7):e250-e254
- Prevalence, course and determinants of carpal tunnel syndrome symptoms during pregnancy: a prospective study — BJOG: An International Journal of Obstetrics and Gynaecology (Meems M, Truijens S, Spek V, Visser LH, Pop VJ). BJOG 2015;122(8):1112-1118
- Local corticosteroid injection versus surgery for carpal tunnel syndrome — Cochrane Database of Systematic Reviews (Ashworth NL, Bland JD, Chapman KM, Tardif G, Albarqouni L, Nagendran A). Cochrane Database Syst Rev 2024;8:CD015101
- Treatments for carpal tunnel syndrome: who does what, when ... and why? — Canadian Family Physician (Taylor-Gjevre RM, Gjevre JA, Strueby L, Boyle CA, Nair B, Sibley JT). Can Fam Physician 2007;53(7):1186-1190
- Splinting for carpal tunnel syndrome — Cochrane Database of Systematic Reviews (Karjalainen TV, Lusa V, Page MJ, O'Connor D, Massy-Westropp N, Peters SE). Cochrane Database Syst Rev 2023;2:CD010003
- Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome — Cochrane Database of Systematic Reviews (O'Connor D, Marshall S, Massy-Westropp N). Cochrane Database Syst Rev 2003;(1):CD003219
- Local corticosteroid injection versus placebo for carpal tunnel syndrome — Cochrane Database of Systematic Reviews (Ashworth NL, Bland JDP, Chapman KM, Tardif G, Albarqouni L, Nagendran A). Cochrane Database Syst Rev 2023;2:CD015148
- Surgical versus non-surgical treatment for carpal tunnel syndrome — Cochrane Database of Systematic Reviews (Lusa V, Karjalainen TV, Pääkkönen M, Rajamäki TJ, Jaatinen K). Cochrane Database Syst Rev 2024;1:CD001552
- Advisory: Use of non-steroidal anti-inflammatory drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage in unborn babies, leading to low amniotic fluid — Health Canada. Health Canada Public Advisory, October 2020 (labelling update June 2021)
Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.